HEALTHIETF Share Price Target 2040

CAGR-based price projection for HEALTHIETF (HEALTHIETF) targeting 2040, derived from official NSE exchange closing prices.

Bear Case (5.2% CAGR)
Rs 334
2040 Target
Base Case (13.0% CAGR)
Rs 907
2040 Target
Bull Case (35.9% CAGR)
Rs 12,056
2040 Target

Current Market Snapshot

CMP: Rs 164.59
52W High: Rs 172.96
52W Low: Rs 145.29
1Y CAGR: 27.6%
3Y CAGR: 13.0%

Year-by-Year Price Projection

YearBear CaseBase CaseBull Case
2027 Rs 173 Rs 186 Rs 224
2028 Rs 182 Rs 210 Rs 304
2029 Rs 192 Rs 237 Rs 413
2030 Rs 201 Rs 268 Rs 561
2031 Rs 212 Rs 303 Rs 763
2032 Rs 223 Rs 342 Rs 1,037
2033 Rs 234 Rs 386 Rs 1,409
2034 Rs 247 Rs 436 Rs 1,914
2035 Rs 259 Rs 493 Rs 2,601
2036 Rs 273 Rs 557 Rs 3,535
2037 Rs 287 Rs 629 Rs 4,804
2038 Rs 302 Rs 711 Rs 6,529
2039 Rs 318 Rs 803 Rs 8,872
2040 Rs 334 Rs 907 Rs 12,056

Other HEALTHIETF Price Targets

2025 2026 2027 2028 2030 2035 2050

Frequently Asked Questions

What is the HEALTHIETF share price target for 2040?

Based on historical growth analysis, the HEALTHIETF share price target for 2040 ranges from Rs 334 (conservative) to Rs 907 (base case) to Rs 12,056 (optimistic). These projections are based on trailing CAGR and should not be treated as guaranteed outcomes.

What is the current share price of HEALTHIETF?

The current market price of HEALTHIETF (HEALTHIETF) is Rs 164.59. The 52-week high is Rs 172.96 and 52-week low is Rs 145.29.

Is HEALTHIETF a good stock to buy for the long term?

Long-term investment decisions depend on individual risk tolerance, financial goals, and portfolio diversification. Examine the company's fundamentals, debt-to-equity ratio, promoter holding, and competitive positioning within its sector. BrokerLens provides data-driven analysis; consult a SEBI-registered financial advisor before investing.

What methodology does BrokerLens use for HEALTHIETF price targets?

BrokerLens computes price targets using historical Compound Annual Growth Rate (CAGR) derived from official NSE closing prices. Three scenarios are modeled: Bear (conservative at 5.2% CAGR), Base (13.0% CAGR), and Bull (optimistic at 35.9% CAGR). These are statistical projections, not guaranteed forecasts.

Disclaimer: Share price targets on BrokerLens are statistical CAGR projections based on historical NSE closing prices. They are NOT guaranteed outcomes, investment advice, or analyst recommendations. Past performance does not guarantee future results. Consult a SEBI-registered investment advisor before making investment decisions. Mutual fund and equity investments are subject to market risks.